Literature DB >> 16087084

Management of the valve and ascending aorta in adults with bicuspid aortic valve disease.

Michael A Borger1, Tirone E David.   

Abstract

Bicuspid aortic valve (BAV) disease is the most common congenital cardiac malformation, being present in 1% to 2% of the population. It is heritable and is three to four times more likely to occur in men. The pathogenesis of BAV disease is unknown. Bicuspid valves progress to aortic stenosis or insufficiency in the majority of patients. BAV disease is associated with several anomalies of the aorta including coarctation, aneurysm formation, and dissection. Several lines of evidence suggest that aortic complications are caused by the same underlying factor that causes BAV disease, rather than being a consequence of turbulent blood flow through a stenotic valve. Several different surgical options exist for patients with BAV disease depending on the age of presentation and the size and appearance of the aorta. We herein describe our surgical management of the aortic valve and ascending aorta in patients with BAV disease.

Entities:  

Mesh:

Year:  2005        PMID: 16087084     DOI: 10.1053/j.semtcvs.2005.02.005

Source DB:  PubMed          Journal:  Semin Thorac Cardiovasc Surg        ISSN: 1043-0679


  8 in total

1.  Management of patients with bicuspid aortic valve disease.

Authors:  Todd L Kiefer; Andrew Wang; G Chad Hughes; Thomas M Bashore
Journal:  Curr Treat Options Cardiovasc Med       Date:  2011-12

Review 2.  Insight into pathologic abnormalities in congenital semilunar valve disease based on advances in understanding normal valve microstructure and extracellular matrix.

Authors:  Elizabeth H Stephens; Debra L Kearney; K Jane Grande-Allen
Journal:  Cardiovasc Pathol       Date:  2011-02-23       Impact factor: 2.185

3.  Rationale and design of the National Registry of Genetically Triggered Thoracic Aortic Aneurysms and Cardiovascular Conditions (GenTAC).

Authors:  Kim A Eagle
Journal:  Am Heart J       Date:  2008-12-17       Impact factor: 4.749

4.  Surgical treatment of patients enrolled in the national registry of genetically triggered thoracic aortic conditions.

Authors:  Howard K Song; Joseph E Bavaria; Mark W Kindem; Kathryn W Holmes; Dianna M Milewicz; Cheryl L Maslen; Reed E Pyeritz; Craig T Basson; Kim Eagle; H Eser Tolunay; Barbara L Kroner; Hal Dietz; Victor Menashe; Richard B Devereux; Patrice Desvigne-Nickens; William Ravekes; Jonathan W Weinsaft; Donald Brambilla; Mario P Stylianou; Tabitha Hendershot; Megan S Mitchell; Scott A LeMaire
Journal:  Ann Thorac Surg       Date:  2009-09       Impact factor: 4.330

Review 5.  Causes and histopathology of ascending aortic disease in children and young adults.

Authors:  Deepali Jain; Harry C Dietz; Gretchen L Oswald; Joseph J Maleszewski; Marc K Halushka
Journal:  Cardiovasc Pathol       Date:  2011 Jan-Feb       Impact factor: 2.185

Review 6.  Surgical treatment of bicuspid aortic valve disease: knowledge gaps and research perspectives.

Authors:  Alessandro Della Corte; Simon C Body; Anna M Booher; Hans-Joachim Schaefers; Rita K Milewski; Hector I Michelena; Arturo Evangelista; Philippe Pibarot; Patrick Mathieu; Giuseppe Limongelli; Prem S Shekar; Sary F Aranki; Andrea Ballotta; Giuseppe Di Benedetto; Natzi Sakalihasan; Gianantonio Nappi; Kim A Eagle; Joseph E Bavaria; Alessandro Frigiola; Thoralf M Sundt
Journal:  J Thorac Cardiovasc Surg       Date:  2014-01-21       Impact factor: 5.209

7.  Current indications for surgical repair in patients with bicuspid aortic valve and ascending aortic ectasia.

Authors:  Christian D Etz; Martin Misfeld; Michael A Borger; Maximilian Luehr; Elfriede Strotdrees; Friedrich-Wilhelm Mohr
Journal:  Cardiol Res Pract       Date:  2012-09-20       Impact factor: 1.866

8.  The Relationship between Arterial Elasticity Parameters of Ascending Aorta, Abdominal Aorta and Carotid Arteries with Carotid Intima Media Thickness in Children with Bicuspid Aortic Valve.

Authors:  Ajda Mutlu Mıhçıoğlu; Feyza Ayşenur Paç; Muharrem Tola; Ahmet Vedat Kavurt; Serhat Koca; Denizhan Bağrul
Journal:  Anatol J Cardiol       Date:  2022-06       Impact factor: 1.475

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.